
Quotient Limited QTNT
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited Langfristiger Schuldenstrom 2011-2026 | QTNT
Langfristiger Schuldenstrom Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 3.45 M | 3.03 M | - | - | - | 1 M | 4.5 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.5 M | 1 M | 2.99 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 518.86 | 0.06 % | $ 15 B | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 22.16 | 26.1 % | $ 1.18 B | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.14 | -6.28 % | $ 1.04 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.29 | -1.38 % | $ 2.01 B | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 28.65 | -1.44 % | $ 20 B | ||
|
Co-Diagnostics
CODX
|
662 K | $ 1.46 | 2.46 % | $ 1.94 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 24.59 | -0.12 % | $ 683 M | ||
|
Senseonics Holdings
SENS
|
496 K | $ 6.78 | -1.74 % | $ 283 M | ||
|
Soleno Therapeutics
SLNO
|
726 K | $ 52.55 | -0.04 % | $ 2.67 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Neuronetics
STIM
|
5.56 M | $ 1.4 | 0.36 % | $ 92.3 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 178.08 | -1.37 % | $ 8.83 B | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 517.85 | -2.6 % | $ 195 B | ||
|
Danaher Corporation
DHR
|
199 M | $ 194.37 | -1.9 % | $ 139 B | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 2.2 | - | $ 9.73 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 55.84 | -3.09 % | $ 3.34 B | ||
|
Illumina
ILMN
|
79 M | $ 132.01 | -0.19 % | $ 21 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 16.19 | 0.12 % | $ 490 M | ||
|
Guardant Health
GH
|
27.7 M | $ 84.8 | -0.07 % | $ 10.6 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
41 K | $ 2.82 | -3.75 % | $ 91.5 K | ||
|
Biomerica
BMRA
|
358 K | $ 2.18 | 3.32 % | $ 5.01 M | ||
|
Waters Corporation
WAT
|
31.1 M | $ 319.4 | -2.09 % | $ 19 B | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 115.49 | -0.87 % | $ 9.53 B | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 266.74 | - | $ 22.2 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Celcuity
CELC
|
54 K | $ 125.73 | 1.83 % | $ 5.88 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 5.03 | -3.06 % | $ 466 M | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 83.43 | -0.61 % | $ 5.63 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 192.03 | 0.32 % | $ 21.3 B |